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of time in sedentary behavior. Sedentary behavior has been linked to poor glycemic control and
increased risk of all-cause mortality. Here, we explore a potential link between sedentary behavior
and brain health. We highlight the role of glycemic control in maintaining brain function and suggest
that reducing and replacing sedentary behavior with intermittent light-intensity physical activity may
protect against cognitive decline by reducing glycemic variability. Given that older adults find it diffi-
cult to achieve current exercise recommendations, this may be an additional practical strategy. How-
ever, more research is needed to understand the impact of poor glycemic control on brain function and
whether practical interventions aimed at reducing and replacing sedentary behavior with intermittent
light intensity physical activity can help slow cognitive decline.
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Dementia, which is an umbrella term for conditions
characterized by cognitive decline, is a growing global
health issue. Combined projections from a meta-analysis
predict that global dementia prevalence will double every
20 years [1]. Dementia prevalence also represents a huge
global economic cost, estimated to be US $604 billion in
2010 [2]. Strategies that can delay or prevent dementia are
urgently needed given the burden it places on individuals,
families, and the wider community. It has been estimatedimer’s Association. This is an open access article under the CC BY-NC-ND
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Alzheimer’s disease (AD), the main cause of dementia
worldwide, compared with no change in onset, there would
be 11.8 million fewer cases of the disease by 2050 [3].
Because there is currently no targeted pharmacotherapy to
reduce the risk of dementia in older adults, there is a need
to investigate modifiable behavioral risk factors that can
attenuate cognitive decline.
Physical activity acts on multiple mechanisms to elicit
improvements in brain health [4]. Most randomized
controlled trials supporting the benefits of physical activ-
ity for brain function have focused on moderate to
vigorous intensity physical activity (MVPA) [4,5]. This
focus is embodied within current public health
guidelines, which are based on achieving a minimal
level of MVPA. For adults (18–64 years) and older
adults (65 years), this is set at 150 minutes/week,
accumulated in bouts .10 minutes [6]. However, nearly
one-third of people worldwide do not achieve this mini-
mum recommended level of MVPA [7]. Moreover, adher-
ence is lowest in older adults, with some estimates
indicating that 55% to 70% do not achieve the minimumFig. 1. This figure is based on accelerometer data from the U.S. National Health a
adults (mean age5 70.5 years; mean body mass index5 29.7 kg/m2) allocate thei
and brain health focuses onMVPA. However, only a very small proportion of the da
sedentary behavior with light-intensity physical activity can improve glycemic con
Abbreviation: MVPA, moderate to vigorous intensity physical activity.recommended level of MVPA [8]. Fig. 1 highlights the
small volume of time during waking hours, which is spent
in MVPA, based on accelerometer data from a sample of
older adults [9]. In contrast, a considerably larger volume
of time is spent in sedentary behavior and light-intensity
activity, but little is known about the implications of these
behaviors for brain health.
Time spent in sedentary behavior and light-intensity
activity may not be benign. Evidence suggests that excessive
sedentary time can increase risk for all-cause mortality and
chronic disease such as type 2 diabetes (T2D), even in the
presence of regular MVPA to the level advocated within
current public health guidelines [10,11]. Extending these
investigations to brain function is a fascinating topic of
current research, with early evidence hinting that sedentary
behavior may also be detrimental to cognitive function
[12]. However, more studies investigating this association
are needed, specifically high-quality studies attempting to
tease out the independent effects of sedentary behavior
from physical activity using objective measures. Also of
importance is understanding how sedentary behavior might
affect brain function. Controlled experiments suggest thatnd Nutrition Examination Survey, which shows how 1367 older, overweight
r time on average throughout the day [9]. Most research on physical activity
y is spent inMVPA. Emerging evidence suggests that replacing time spent in
trol. However, little is known about the implications of this for brain health.
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control, but reducing and replacing sedentary behavior with
intermittent light-intensity activity can ameliorate this effect
[13]. In this perspectives article, we outline the potential im-
plications of this for brain function. To do this we first estab-
lish how hyperglycemia, hypoglycemia, and cerebral blood
flow (CBF) affect brain physiology.We next discuss how dy-
namic interactions between glycemic control and CBF may
influence brain health. Finally, we propose a hypothesis that
reducing and replacing sedentary behavior with light-
intensity physical activity may protect against cognitive
decline by reducing glycemic variability and increasing
CBF. In doing so, we highlight future opportunities for
both researchers and health practitioners. We argue that
not only have current public health approaches failed to
motivate a large proportion of the population to reach targets
for MVPA, but focusing solely on MVPA ignores the poten-
tial health benefits of regular engagement in activities of a
lighter intensity. Such evidence may be especially useful
in the context of older adults who find it difficult to achieve
targets for MVPA.2. Glycemic control and brain health
The human brain, which accounts for about 2% of body
weight, consumes about 20% of the energy required for
resting metabolic rate—the minimum energy expenditure
required to sustain life [14]. Most of this energy demand is
met by utilizing glucose as a fuel, which places importance
on glycemic control for maintaining brain health. At the
cellular level, glycemic control is dependent on glucose
transporters. The transport of glucose across the blood-
brain barrier into the extracellular space and subsequent up-
take by brain parenchymal cells is facilitated by a concentra-
tion gradient, as the transporters responsible are insulin-
insensitive transporters such as glucose transporters 1 and 3
(GLUT1 and GLUT3) [15]. In this way, circulating glucose
concentration regulates central glucose levels, a mechanism
which may play a role in the neuropathology associated
with chronic perturbations of circulating glucose [16].
Indeed, older adults with T2D are some 50% more likely
to develop dementia relative to those with normal glucose
metabolism [17]. Even in individuals without diabetes,
higher fasting glucose and HbA1c, which is a measure of
average glucose levels over 2 to 3 months, are associated
with an increased risk for dementia [18]. Imaging techniques
in cognitively normal adults with both prediabetes and T2D
indicate that functional change related to glucose meta-
bolismmay be an early indicator of AD risk [19]. To help un-
derstand the potential link between glucose levels and
dementia risk, we explore the dynamics of hyperglycemia,
hypoglycemia, and CBF. We acknowledge that this is a
glucose-centric view and that other mechanisms including
insulin resistance, chronic low-grade inflammation, and
oxidative stress contribute to neuropathology, but these as-
pects are beyond the scope of the present article.3. Hyperglycemia and cerebral glucose kinetics
Exposure to hyperglycemia can result in decreased blood
to brain glucose transport. This concept was first put forward
in 1958 when Wyke described “relative cerebral hypoglyce-
mia” [20]. This condition was identified in patients who dis-
played symptoms of hypoglycemia such as headache,
confusion, and motor seizure in the presence of a normal
circulating glucose concentration, where symptoms were
relieved after an increase in plasma glucose. The first exper-
imental evidence of altered blood to brain glucose transport
after prolonged hyperglycemia was published in 1981 [21].
It was reported that in rats prolonged exposure to hypergly-
cemia followed by a return of glucose levels to normal
values inhibited glucose transport into the brain by some
20%, compared with controls [21]. In cognitively normal hu-
mans with prediabetes and T2D, insulin resistance—a
marker of disease severity—was associated with reduced ce-
rebral glucose metabolism [19]. Taken together, this indi-
cates that hyperglycemia may reduce cerebral glucose
metabolism, which could serve initially as a protective
mechanism. However, we hypothesize that this protective
mechanism may work to exaggerate the effects of subse-
quent hypoglycemia and ultimately damage brain paren-
chymal cells by disrupting vital energy supply.4. Hypoglycemia and brain function
Exposure to hypoglycemia can impair cognition, espe-
cially for complex tasks, which may be more sensitive to hy-
poglycemic impairment. For example, participants with type
1 diabetes who were tested in a driving simulator made more
errors when blood glucose was 3.4 to 4.0 mmol/L, compared
with driving in the range of 5.6 to 8.3 mmol/L [22]. However,
repeated exposure to hypoglycemia may have more serious
implications as there is a dose-dependent relationship be-
tween a higher number of severe hypoglycemic episodes
and increased risk for dementia [23]. The biological mecha-
nisms underpinning the detrimental impact of hypoglycemia
on the brain are not fully understood, although insights may
come from evidence which highlights a role for glucose con-
centration in regulating apoptosis, the process of cell death.
Glucose concentration may regulate apoptosis in the
brain via a key enzyme of glucose metabolism, hexokinase
II (HKII). In neurons and other cells, HKII catalyzes the for-
mation of glucose-6-phosphate, which is the first step in
most glucose metabolism pathways. However, HKII has
also been described as a metabolic switch capable of turning
on and off apoptosis [24]. Under conditions of glucose depri-
vation, HKII activates apoptosis. This places neurons, with
their heavy reliance on glucose, as being particularly suscep-
tible to apoptosis when fuel supply is disrupted [24].
Neuronal apoptosis has serious consequences, as this pro-
cess is activated in neurodegenerative diseases like AD
[25]. Importantly, controlled regulation of glucose protects
neurons from apoptosis [24]. The exact concentration of
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apoptosis is unknown. However, given the brain’s high de-
mand for energy, it is logical to suspect that repeated expo-
sures below such a threshold may induce an energy crisis and
allow progressive damage to accumulate over time.5. Defense against neuroglycopenia
Because of the danger posed by a lack of glucose in the
brain, known as neuroglycopenia, humans have evolved
defensive mechanisms that are initiated when blood
glucose falls below the range of 3.6 to 3.8 mmol/L [26].
As glucose levels fall, there is a decrease in secretion of
insulin and increased secretion of glucagon and epineph-
rine to increase glucose levels [26]. However, this defense
can be blunted by a single antecedent exposure to hypogly-
cemia in healthy people [27]. In those with type 1 diabetes
and advanced T2D, this compromised defense can be more
exaggerated as it occurs in a setting of relative pancreatic b
cell failure and failure of endocrine regulation of hypogly-
cemia. This compromising milieu has been called “hypo-
glycemia-associated autonomic failure,” which has
several purported mechanisms, the details of which can
be found elsewhere [28].
Although antecedent hypoglycemia blunts the endocrine
defense against hypoglycemia, a backup mechanism exists
that acts to increase glucose transport into the brain. This
is likely achieved via increases in CBF and upregulation of
glucose transporters (GLUT1 and GLUT3), although human
evidence for the latter is lacking. However, this backup
mechanism takes time to manifest. For example, in healthy
participants, 56 hours exposure to interprandial hypoglyce-
mia (2.9 mmol/L) effectively blunted endocrine counter
regulation to subsequent hypoglycemia [29]. However, this
occurred in the presence of adaptive increases in CBF and
brain glucose uptake which preserved cognitive function,
relative to hypoglycemic exposure following normal glucose
levels, in the same participants [29]. In another study of
healthy participants, three exposures to a 30-minute bout
of hypoglycemia (2.8 mmol/L) over a 24-hour period effec-
tively blunted endocrine counter-regulation without any
adaptive change in blood to brain glucose transport or cere-
bral glucose metabolism [30]. Taken together, these findings
indicate that brief exposures to hypoglycemia may be more
conducive to neuroglycopenia than prolonged exposure,
because endocrine counter-regulation is compromised faster
than the brain can increase blood to brain glucose transport.6. Blood flow: supplying vital energy to the brain
Brain function is subserved by CBF as the mechanism of
substrate delivery. In turn, energy demand in the brain can
tightly regulate CBF. The mechanisms that match local
neuronal energy demand to glucose and oxygen delivery are
dynamic, to protect the brain from potentially hazardous
declines in blood glucose. Neuronal energy demand iscommunicated to the vasculature by vasoactive neurotrans-
mitters, particularly glutamate and by-products of synaptic
signaling [31]. Regional CBF is regulated at the level of
arterioles via smooth muscle cells and at the capillary level
via the pericyte cells, which surround capillaries and can
induce constriction or dilation. A comprehensive review of
themechanisms involved is available elsewhere [32]. Because
of the tight coupling of CBF to brain function, impaired CBF
can have serious consequences for brain health.
Hypoperfusion of the brain may be both a consequence
and a cause of early neurodegeneration in both vascular
dementia and AD. In healthy participants, ingestion of
glucose has been shown to reduce regional CBF [33]. This
hints that CBF is acutely sensitive to glucose levels. Both
prolonged exposure to hyperglycemia and repeated exposure
to hypoglycemia can induce microvascular damage and
impair endothelial function leading to cerebral hypoperfu-
sion [34,35]. In a rat model of chronic hypoperfusion,
oxygen and nutrient supply to the brain is reduced,
damaging the blood brain barrier, neurons, astrocytes and
microglial cells, as well as impairing learning and memory
[36]. Reduced CBF also slows the clearance of proteins
like amyloid b from the perivascular space [37]. Amyloid
b accumulation, which is implicated in the pathogenesis of
AD, is toxic to the pericytes surrounding capillaries [38].
Amyloid b accumulation may also eventually affect larger
blood vessels causing endothelial cell damage, vasoconstric-
tion, and a decrease in CBF [39]. In those with AD, faster
deterioration in regional CBF is positively associated with
a more rapid decline in cognition [40]. Thus, once estab-
lished, hypoperfusion may result in a vicious cycle leading
to further decreases in perfusion conducive to neurodegener-
ative disease. Taken together, these findings highlight the
importance of protecting the brain from declines in CBF.7. Brain exposure to glucose excursions
On a daily basis there are dynamic interactions among
hyperglycemia, hypoglycemia, and CBF, the severity of
which may have implications for brain health. Clarifying
how these dynamic physiological states interact with each
other may help us understand the effects of poor glycemic
control on the brain. We hypothesize that under repetitive
conditions of hyperglycemia and hypoglycemia, such that
when one follows the other in a continued pattern, a
negative feedback loop is established, which can shift brain
physiology toward pathophysiology. Fig. 2 illustrates brain
exposure to circulating glucose excursions at an early stage
of damage in a hypothetical individual.
In dysglycemic individuals, the damage sustained by the
brain from poor glycemic control may be exacerbated.
Fig. 3 depicts both circulating and central glucose levels in
a hypothetical individual with an increased fasting glucose
level. The increased time spent in hyperglycemia results in
adaptation to inhibit blood to brain glucose transport. This
adaptation works to lower central glucose concentration
Fig. 2. The effects of circulating glucose on the brain at an early stage of damage. This schematic illustrates circulating glucose excursions in response to meals
in a hypothetical individual. (1) Acute hyperglycemia in this scenario causes a reduction in regional CBF and a spike in insulin levels to facilitate glucose clear-
ance. (2) These two factors combine to result in a glucose nadir. This glucose nadir can act to impair endocrine counter-regulation to a subsequent dip in glucose,
exaggerating the hypoglycemic episode. As this happens over the space of a day, there is not enough time for the brain to compensate via increased CBF or
upregulation of glucose transporters. (3) The result is an exaggerated hypoglycemic episode, which can impair endothelial function. This hypoglycemic episode
may also be mirrored in the central concentration, depriving neurons of glucose, resulting in an energy crisis. Such a pattern, if continued, may progressively
damage the brain. Abbreviation: CBF, cerebral blood flow.
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circumstances, it is conceivable that at a normal peripheral
concentration of glucose the brain can experience hypoglyce-
mia. This phenomenon is termed relative cerebral hypoglyce-Fig. 3. Brain exposure to glucose excursions at a late stage of damage. This schematic
in a hypothetical individual with increased fasting glucose level. (1) The increased tim
tion of brain arterioles, resulting in chronic hypoperfusion and decreased blood to brain
to decreased glucose transport, although human evidence for this is lacking. (2) Thi
concentration. Thismeans that the brainmay experience hypoglycemia at a normal cir
(3) The ensuing exposure to hypoglycemia can disable endocrine counter-regulation to
gerated and the ensuing energy crisis may induce neuroglycopenia and the accumulamia. Ensuing exposure to hypoglycemia can cause an energy
crisis, which can induce neuroglycopenia and further impair
CBF, paving the way for a recurring pattern of hypoglycemia
and associated damage. This accumulating damage mayillustrates both circulating and central glucose excursions in response to meals
e spent in hyperglycemia induces damage to pericytes and endothelial dysfunc-
glucose transport. Downregulation of glucose transporters may also contribute
s protective mechanism works to lower central glucose relative to circulating
culating glucose level, a phenomenon known as relative cerebral hypoglycemia.
subsequent hypoglycemia. (4) Exposure to subsequent hypoglycemia is exag-
ting damage could move the brain toward neuropathology.
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neuropathology.
Taken together, in an acute setting, switching between
hyperglycemia and hypoglycemia allows for an exaggerated
glucose nadir and insufficient time for the brain to induce
protective mechanisms. This effect is inflated in those with
increased fasting glucose levels whomay experience relative
cerebral hypoglycemia. Given the damage associated with
neuroglycopenia, a continued and repeated pattern of exces-
sive glucose excursions could shift brain physiology toward
pathophysiology. In the following sections, we will discuss
how interventions might manipulate glycemic control with
the aim of preserving cognitive function.8. Implications of glycemic control for brain health
Evidence from a recent systematic review supports the
notion that over time, poor glycemic control can impair
brain structure and function [41]. However, randomized
controlled trials which have investigated this show mixed
results. For example, a large trial did not support the idea
that intensive glycemic control (HbA1c ,6.0%) was
associated with improved cognitive function relative to
standard therapy (HbA1c , 7.0%–7.9%) after 40 weeks
for those with T2D [42]. However, glycemic control was
achieved in this trial using antidiabetic drugs (physician
guided, individually tailored to reach target HbA1c).
Therefore, the adverse effects of this pharmacotherapy
may have influenced cognitive function directly. Moreover,
glycemic control was defined by HbA1c—a measure of
average glucose—which does not capture daily glucose ex-
cursions or variability. In a cross-sectional study of 121
older adults with T2D, a measure of glucose variability
called the mean amplitude of glycemic excursions (average
amplitude of glucose excursions, upward and downward,
that are .1 standard deviation) was associated with mea-
sures of cognitive function (Mini–Mental State Examina-
tion and a composite score of attention and executive
functioning) [43]. Importantly, this association was
independent of fasting glucose, postprandial glycemia and
HbA1c—suggesting that glycemic variability itself may
be worthy of consideration. Although glycemic variability
is more difficult to measure than HbA1c, future trials inves-
tigating the effects of glycemic control on brain health
should attempt to include it as a measure.
This evidence highlights the potential complications
associated with pharmacotherapy for improving cognition
by targeting glycemic control. Achieving glycemic control
via pharmacotherapymay even be counterproductive, result-
ing in an increased number of hypoglycemic events, weight
gain, and increased mortality following intensive glycemic
control, relative to standard therapy [42]. Physical activity,
on the other hand, has multiple benefits including better gly-
cemic control and improved cognitive function, and may
represent a superior treatment option for protecting brain
health. However, there has been increasing attention givento the notion that physical activity behaviors exist across a
spectrum of intensity, which could have important chal-
lenges and practical implications for older adults.9. Intensity of physical activity: implications for older
individuals
Physical activity behaviors exist across a spectrum of
energy expenditure, from sedentary (e.g., quiet sitting), to
light-intensity (e.g., gentle walking), through to highly
intense (e.g., sprinting) activities. Each of these behaviors
may have different implications for glycemic control and
brain health. To date, most evidence has investigated the
health implications of MVPA. However, for older adults,
the vast majority of time is spent in activities of a lower in-
tensity, particularly sedentary behavior, which is defined by
its low energy expenditure and a sitting or lying posture [44].
The implications of sedentary behavior (too much sitting) is
a topic that has gained much interest lately. For example, a
recent meta-analysis of 16 prospective studies with more
than 1 million participants indicated a dose-dependent rela-
tionship of increased risk for all-cause mortality with higher
levels of sitting combined with lower levels of moderate
intensity exercise [10]. However, only a high volume of
moderate intensity exercise (60–75 minutes/day) appeared
to eliminate the increased risk of death from a high amount
of sitting (81 hours/day) [10]. Achieving this amount of
exercise may be less feasible, particularly for older adults,
than reducing sitting time, in which the goal is to replace
or interrupt prolonged sitting with more light-intensity activ-
ity. Indeed, objectively measured sedentary behavior and
light-intensity activity are strongly and inversely correlated
(r 5 20.98) [45]. Therefore, reductions in sedentary time
are most likely to be achieved via replacement with light-
intensity activities. However, whether this can help protect
from cognitive decline is unknown.
A recent systematic review of observational evidence,
which included three prospective studies, examined the
association between sedentary behavior and cognitive func-
tion [12]. The authors concluded that increased sedentary
behavior is associated with lower cognitive function. Howev-
er, there were only eight studies included and heterogeneity
prevented a calculation of the magnitude of this association.
To further inform this observational evidence, controlled
experimental evidence is needed. In addition, further insights
may come from the evidence linking sedentary behavior to
glycemic control, given the importance of glycemic control
in maintaining optimal cognitive function.10. Reducing sedentary behavior: implications for
glycemic control
Observational and experimental evidence highlights the
detrimental associations that exist between sedentary
behavior and glycemic control. A meta-analysis of observa-
tional studies indicates that excessive sitting time can
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mains after controlling for currently recommended levels of
MVPA [11]. Moreover, a number of experimental studies in
healthy participants and those with T2D have demonstrated
that regularly interrupting prolonged sitting with brief light-
intensity activity breaks can improve postprandial glycemic
control [13]. Potential mechanisms for this improvement are
likely to involve muscle contraction and localized increases
in skeletal muscle glucose uptake, mediated by both the insu-
lin and contraction-mediated (insulin-independent) glucose
uptake pathways [46]. Fig. 4 depicts the acute effects of
sedentary behavior and light-intensity activity on glycemic
control in response to a meal in two hypothetical scenarios.
The greatest improvements in glycemic control in
response to reducing and breaking up sitting time have
been observed in participants with T2D [47]. This makes
sense as T2D is characterized by disordered regulation of
glucose levels. In one study of 19 overweight/obese partici-
pants with T2D, the effects of three different activity
regimens were compared [48]. Each regimen lasted 4 days
in duration and were performed in a randomized order,
with a 10 day washout between regimens that were as fol-
lows: (1) Sitting: 4415 steps/day with sitting 14 hours/day;
(2) Exercise: 4823 steps/day with 1.1 hour/day of sitting
replaced with three consecutive 20-minute bouts ofFig. 4. The effects of sedentary behavior versus light-intensity activity on postpra
levels in response to a meal, in two hypothetical scenarios. Dashed lines represent t
prolonged sitting, a lack of contraction-stimulated glucose uptake leads to more ex
tivity, glucose levels are more likely to stay within the optimal range.moderate to vigorous cycling, performed at least 2 hours
after breakfast; and (3) “Sit Less”: 17,502 steps/day with
4.7 hours/day of sitting replaced with intermittent standing
(2.5 hours) and light-intensity walking (2.2 hours) across
the day. All meals and snacks were standardized for days 3
and 4 of each regimen and the primary outcome was
24-hour glycemic control measured on day 4 of each
regimen. Results demonstrated that the “Sit Less” regimen
reduced mean 24-hour glucose, 24-hour glucose excursions,
and duration of hyperglycemia (glucose .10 mmol/L)
compared with the “Sitting” regimen. In addition, an
estimate of insulin resistance called the homeostatic model
assessment for insulin resistance (HOMA-IR), was also
reduced following the “Sit Less” compared with the
“Sitting” regimen. The “Exercise” regimen also tended to
improve these outcomes, albeit to a lesser magnitude than
“Sit Less” despite a comparable energy expenditure. The
results of this study have generated some important
discussion around potential implications [49]. The implica-
tions pertaining to glycemic control are that: (1) exercise
bouts performed in the morning may not fully compensate
for the negative effects of prolonged sitting for the rest of
the day; and (2) the duration and frequency of physical activ-
ity, aided by timing around meals, may be more important
than the intensity of physical activity.ndial glucose profile. This figure illustrates circulating glucose and insulin
he optimal glucose range between hyperglycemia and hypoglycemia. During
treme glucose excursions. In the presence of intermittent light-intensity ac-
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breaking up sitting time with intermittent light-intensity
activity may offer an additional option to structured bouts
of MVPA. Considering that the kinetics of central glucose
is determined mainly by a concentration gradient, it could
be speculated that to some extent, changes in circulating
glucose levels may be mirrored in the central concentration,
especially in the acute setting. With this in mind, we now
discuss some evidence for the effects of light-intensity activ-
ity on central glucose kinetics and brain function.11. Light-intensity activity: implications for central
glucose and brain function
Light-intensity activity may elicit beneficial effects on
central glucose kinetics, which, in turn, could serve to protect
the brain from excessive glucose excursions. In one study of
healthy male participants, a 35-minute bout of light-intensity
cycling (30% of the maximum volume of oxygen uptake,
which is a measure of exercise intensity) resulted in 30%
more brain glucose uptake compared with higher intensity
cycling (75% of the maximum volume of oxygen uptake)
[50]. This is likely because of the preferential use of lactate
by the brain in place of glucose during higher intensity activ-
ity. In addition, light-intensity cycling has been shown to in-
crease CBF relative to seated baseline in healthy male
participants [51]. This suggests that light-intensity activity
could increase delivery of glucose to the brain and may be
protective during hypoglycemia. However, research investi-
gating whether light-intensity activity has a meaningful pro-
tective effect on the brain during hypoglycemia and whether
this has implications for cognitive function is lacking.
There is a paucity of evidence on the acute effects of
light-intensity activity on cognitive function. A recent
trial in 19 healthy but overweight adults (mean
age 5 57.9 years, mean body mass index 5 31.7 kg/m2)
compared two 7-hour conditions separated by a 6-day
washout: (1) prolonged sitting; and (2) sitting interrupted
by intermittent light-intensity walking breaks (3 minutes
walking every 30 minutes, total of 30 minutes walking)
[52]. Cognitive function, neuroendocrine biomarkers, and
subjective fatigue were measured at multiple time points
across the day. Although a trend for improvement in episodic
memory was observed in the light-intensity walking condi-
tion, the difference was nonsignificant. However, there was
a significant improvement in subjective fatigue. The study
was likely underpowered to detect any effect on cognition
attributable to the 30 minutes of total accumulated walking.
In another study, healthy but overweight adults performed
2.5 hours of accumulated walking breaks across an 8-hour
day, the results demonstrated improved scores on a battery
of cognitive tests (z-score effect size of d 5 0.71), relative
to 8 hours of sitting [53].
This said, it may be that the greatest benefit of light-
intensity activity for the brain does not manifest in the acute
setting, but rather over a longer period of time following pro-tection from repeated glucose excursions. However, longer
term trials investigating whether light-intensity activity can
protect against cognitive decline are lacking. In one study of
dementia patients in a nursing home setting, a 9-month tai
chi intervention successfully preserved cognitive function
relative to a control group who performed simple handicrafts
[54]. However, tai chi may be different to other forms of
light-intensity activity, as it requiresmemorization of complex
moves, making it difficult to generalize to other forms of light-
intensity activity. A recent meta-analysis examined random-
ized controlled trials of walking interventions in sedentary
older adults with executive function as an outcome, showing
a small overall benefit but only for those without cognitive
impairment [55]. However, low adherence in thosewith cogni-
tive impairmentmay have confounded results and the intensity
of all walking interventions was not reported and likely con-
tained a mix of light and moderate intensity interventions.
Taken together, the evidence to date hints that excessive
sedentary timeand thus insufficient light-intensity activity could
be detrimental to both glycemic control and cognition, however,
more research is needed. Experimental models in the acute
setting have highlighted the benefits of replacing sedentary
behaviorwith light-intensity activity for glycemic control, espe-
cially after meals. Given the potential damage to the brain
caused by poor glycemic control over time, future research
should investigate whether chronic interventions aimed at
increasing intermittent light-intensity activity may also protect
from cognitive decline. From a public health perspective, this
is likely to havemanyadvantages,most notably due to broadop-
portunities to imbedmore light-intensity activity throughout the
day. This may be especially important for older adults who find
it difficult to engage in MVPA.12. Conclusion
There is a clear need for effective and feasible interven-
tion strategies to help preserve brain health and cognition
in older adults. Evidence-based public health messages
have emphasized MVPA for its ability to improve cognitive
function. Despite this, older adults spend very little time
doing MVPA on a daily basis. The greatest proportion of
time is spent in activities of a lower intensity, which may
have implications for glycemic control and ultimately brain
health. The take homemessage is that reducing and breaking
up sitting time with intermittent light-intensity activity may
play a role in maintaining glycemic control and optimal
brain health. While structured MVPA retains distinct physi-
ological adaptations important for improving cognitive func-
tion, reducing and replacing sedentary behavior with
intermittent light-intensity activity may be important in fore-
stalling cognitive decline. However, the evidence-base sup-
porting this idea is currently lacking and should be a target
for future research. Such evidence would provide an addi-
tional option, alongside structured MVPA, in the arsenal of
targeted interventions, policies, and programme develop-
ment aimed at preventing dementia.
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1. Systematic review: We reviewed the literature
relating to sedentary behavior, glycemic control,
and cognitive decline on relevant databases (Medline
and Embase).
2. Interpretation: Older adults spend most of time in
sedentary behavior and this may contribute to cogni-
tive decline via effects on glycemic control. We pro-
pose a hypothesis that reducing and replacing
sedentary behavior with light-intensity physical ac-
tivity may protect against cognitive decline by
reducing glycemic variability and increasing cere-
bral blood flow.
3. Future directions: Specifically future research should
focus on understanding: (1) the mechanisms under-
pinning neuroglycopenia; (2) whether reducing and
replacing sedentary behavior with intermittent
light-intensity activity has any additive benefit to
glycemic control or cognition over and above exer-
cise at a moderate to vigorous intensity; (3) whether
engaging in intermittent light-intensity activity is a
feasible intervention, which can forestall cognitive
decline in those who struggle to engage in moderate
to vigorous intensity physical activity.References
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